Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Lisa D Earnhardt. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Lisa D Earnhardt har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:ABT / Abbott Laboratories EVP AND GROUP PRESIDENT 71.928
US:XENT / Intersect ENT Inc Director 48.333
US:NVRO / Nevro Corp. Director 5.303
US:KNSY / Kensey Nash Corp Director 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Lisa D Earnhardt. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Lisa D Earnhardt som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-03-07 2025-03-07 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -200 71.928 -0,28 136,64 -27.329 9.828.602
2025-03-07 2025-03-07 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 200 72.128 0,28 80,98 16.196 5.840.925
2025-03-07 2025-03-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -91.167 71.928 -55,90 133,82 -12.199.968 9.625.405
2025-03-07 2025-03-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 91.167 163.095 126,75 80,98 7.382.704 13.207.433
2025-03-04 2025-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -8.322 71.928 -10,37 135,87 -1.130.710 9.772.857
2025-02-27 2025-02-25 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 18.788 80.250 30,57
2024-05-08 2024-05-07 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -22.852 61.462 -27,10 106,25 -2.428.119 6.530.589
2024-03-04 2024-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -694 84.314 -0,82 118,50 -82.239 9.991.209
2024-03-04 2024-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -7.669 85.008 -8,27 120,05 -920.663 10.205.210
2024-02-23 2024-02-21 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 17.240 92.677 22,85
2023-03-02 2023-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -943 75.437 -1,23 100,70 -94.960 7.596.506
2023-03-02 2023-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -7.631 76.380 -9,08 99,77 -761.345 7.620.433
2023-02-22 2023-02-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 15.855 84.011 23,26
2022-06-14 2022-06-10 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -19.592 68.156 -22,33 112,71 -2.208.214 7.681.863
2022-06-14 2022-06-10 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -2.882 87.748 -3,18 112,71 -324.830 9.890.077
2022-03-02 2022-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -943 90.630 -1,03 118,15 -111.416 10.707.962
2022-03-02 2022-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -5.168 91.573 -5,34 122,41 -632.615 11.209.451
2022-02-23 2022-02-18 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 80.380 80.380
2022-02-23 2022-02-18 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 17.247 96.741 21,70
2021-06-11 2021-06-10 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -2.881 79.494 -3,50 109,05 -314.173 8.668.821
2021-03-02 2021-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -943 82.375 -1,13 120,61 -113.735 9.935.249
2021-03-02 2021-02-26 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -2.621 83.318 -3,05 121,58 -318.661 10.129.802
2021-02-23 2021-02-19 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 71.070 71.070
2021-02-23 2021-02-19 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 13.865 85.939 19,24
2020-06-12 2020-06-10 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -872 72.074 -1,20 90,84 -79.216 6.547.490
2020-06-12 2020-06-10 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -2.855 72.946 -3,77 90,27 -257.721 6.584.835
2020-02-25 2020-02-21 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 114.940 114.940
2020-02-25 2020-02-21 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 18.855 75.801 33,11
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
A - Award 48.333 48.333
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
D - Sale to Issuer -48.333 0 -100,00
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
A - Award 45.500 45.500
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
D - Sale to Issuer -45.500 0 -100,00
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
A - Award 196.875 196.875
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
D - Sale to Issuer -196.875 0 -100,00
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
A - Award 150.000 150.000
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
D - Sale to Issuer -150.000 0 -100,00
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
A - Award 19.688 19.688
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
D - Sale to Issuer -19.688 0 -100,00
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
A - Award 44.625 44.625
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
D - Sale to Issuer -44.625 0 -100,00
2019-06-12 2019-06-10 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 91.367 91.367
2019-06-12 2019-06-10 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 39.515 56.946 226,69
2019-06-12 2019-06-10 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 17.431 17.431
2019-06-12 3 ABT ABBOTT LABORATORIES
Common shares without par value
0
2019-05-17 2019-05-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -9.500 140.000 -6,35
2019-05-17 2019-05-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -9.500 421.983 -2,20 25,59 -243.102 10.798.418
2019-05-17 2019-05-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 9.500 431.483 2,25 13,05 123.975 5.630.853
2019-04-17 2019-04-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -6.016 48.333 -11,07
2019-04-17 2019-04-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -7.500 149.500 -4,78
2019-04-17 2019-04-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -29.588 421.983 -6,55 28,43 -841.243 11.997.778
2019-04-17 2019-04-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 6.016 451.571 1,35 1,20 7.219 541.885
2019-04-17 2019-04-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 7.500 445.555 1,71 13,05 97.875 5.814.493
2019-01-18 2019-01-16 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
A - Award 157.500 157.500
2019-01-18 2019-01-16 4 XENT Intersect ENT, Inc.
Common Stock
A - Award 33.800 438.055 8,36
2019-01-03 2019-01-01 4 XENT Intersect ENT, Inc.
Common Stock
F - Taxes -10.428 404.255 -2,51 26,57 -277.046 10.740.045
2018-12-26 2018-12-20 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -35.000 54.349 -39,17
2018-12-26 2018-12-20 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 35.000 414.683 9,22 1,20 42.000 497.620
2018-12-19 2018-12-17 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -5.000 157.000 -3,09
2018-12-19 2018-12-17 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 379.683 -5,00 29,73 -594.504 11.286.153
2018-12-19 2018-12-17 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 5.000 399.683 1,27 13,05 65.250 5.215.863
2018-11-19 2018-11-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -5.000 162.000 -2,99
2018-11-19 2018-11-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 394.683 -4,82 30,01 -600.296 11.846.331
2018-11-19 2018-11-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 5.000 414.683 1,22 13,05 65.250 5.411.613
2018-10-17 2018-10-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -5.000 167.000 -2,91
2018-10-17 2018-10-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 409.683 -4,65 29,63 -592.614 12.139.194
2018-10-17 2018-10-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 5.000 429.683 1,18 13,05 65.250 5.607.363
2018-09-19 2018-09-17 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -5.000 172.000 -2,82
2018-09-19 2018-09-17 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 424.683 -4,50 29,14 -582.862 12.376.579
2018-09-19 2018-09-17 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 5.000 444.683 1,14 13,05 65.250 5.803.113
2018-08-17 2018-08-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -5.000 177.000 -2,75
2018-08-17 2018-08-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 439.683 -4,35 26,51 -530.194 11.655.864
2018-08-17 2018-08-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 5.000 459.683 1,10 13,05 65.250 5.998.863
2018-07-18 2018-07-16 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -5.000 182.000 -2,67
2018-07-18 2018-07-16 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 454.683 -4,21 33,08 -661.686 15.042.869
2018-07-18 2018-07-16 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 5.000 474.683 1,06 13,05 65.250 6.194.613
2018-06-19 2018-06-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -5.000 187.000 -2,60
2018-06-19 2018-06-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 469.683 -4,08 36,79 -735.710 17.277.524
2018-06-19 2018-06-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 5.000 489.683 1,03 13,05 65.250 6.390.363
2018-05-23 2018-05-21 4 NVRO NEVRO CORP
Common Stock
A - Award 3.785 5.303 249,34
2018-05-17 2018-05-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -15.000 192.000 -7,25
2018-05-17 2018-05-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -15.000 484.683 -3,00 39,22 -588.244 19.007.474
2018-05-17 2018-05-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 15.000 499.683 3,09 13,05 195.750 6.520.863
2018-04-17 2018-04-16 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -15.000 207.000 -6,76
2018-04-17 2018-04-16 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -15.000 484.683 -3,00 39,59 -593.918 19.190.781
2018-04-17 2018-04-16 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 15.000 499.683 3,09 13,05 195.750 6.520.863
2018-03-16 2018-03-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -15.000 222.000 -6,33
2018-03-16 2018-03-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -15.000 484.683 -3,00 38,32 -574.791 18.572.762
2018-03-16 2018-03-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 15.000 499.683 3,09 13,05 195.750 6.520.863
2018-02-16 2018-02-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -15.000 237.000 -5,95
2018-02-16 2018-02-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -15.000 484.683 -3,00 36,40 -545.938 17.640.474
2018-02-16 2018-02-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 15.000 499.683 3,09 13,05 195.750 6.520.863
2018-01-19 2018-01-18 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -11.166 484.683 -2,25 33,47 -373.695 16.220.983
2018-01-19 2018-01-17 4 XENT Intersect ENT, Inc.
Stock Options (Right to buy)
A - Award 119.000 119.000
2018-01-19 2018-01-17 4 XENT Intersect ENT, Inc.
Common Stock
A - Award 25.500 495.849 5,42
2018-01-03 2018-01-01 4 XENT Intersect ENT, Inc.
Common Stock
F - Taxes -6.834 470.349 -1,43 33,93 -231.897 15.960.259
2017-12-18 2017-12-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -2.000 6.016 -24,95
2017-12-18 2017-12-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -10.685 477.183 -2,19 31,87 -340.512 15.206.963
2017-12-18 2017-12-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 2.000 487.868 0,41 1,20 2.400 585.442
2017-11-17 2017-11-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -10.000 8.016 -55,51
2017-11-17 2017-11-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 485.868 -3,95 27,88 -557.620 13.546.486
2017-11-17 2017-11-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 10.000 505.868 2,02 1,20 12.000 607.042
2017-10-17 2017-10-16 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -10.000 18.016 -35,69
2017-10-17 2017-10-16 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 495.868 -3,88 28,37 -567.336 14.066.188
2017-10-17 2017-10-16 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 10.000 515.868 1,98 1,20 12.000 619.042
2017-09-19 2017-09-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -10.000 28.016 -26,30
2017-09-19 2017-09-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 505.868 -3,80 30,19 -603.870 15.273.925
2017-09-19 2017-09-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 10.000 525.868 1,94 1,20 12.000 631.042
2017-08-17 2017-08-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -10.000 38.016 -20,83
2017-08-17 2017-08-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 515.868 -3,73 30,79 -615.810 15.883.834
2017-08-17 2017-08-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 10.000 535.868 1,90 1,20 12.000 643.042
2017-08-17 2017-08-09 4 XENT Intersect ENT, Inc.
Common Stock
G - Gift -35.000 525.868 -6,24
2017-07-18 2017-07-17 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -10.000 48.016 -17,24
2017-07-18 2017-07-17 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 560.868 -3,44 29,03 -580.642 16.283.176
2017-07-18 2017-07-17 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 10.000 580.868 1,75 1,20 12.000 697.042
2017-06-19 2017-06-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -2.625 58.016 -4,33
2017-06-19 2017-06-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -7.375 0 -100,00
2017-06-19 2017-06-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 570.868 -3,38 26,10 -521.978 14.899.027
2017-06-19 2017-06-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 7.375 590.868 1,26 1,20 8.850 709.042
2017-06-19 2017-06-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 2.625 583.493 0,45 1,20 3.150 700.192
2017-05-30 2017-05-25 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
A - Award 3.545 3.545
2017-05-30 2017-05-25 4 NVRO NEVRO CORP
Common Stock
A - Award 1.518 1.518
2017-05-16 2017-05-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -10.000 7.375 -57,55
2017-05-16 2017-05-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 580.868 -3,33 22,98 -459.520 13.346.023
2017-05-16 2017-05-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 10.000 600.868 1,69 1,20 12.000 721.042
2017-04-18 2017-04-17 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -10.000 17.375 -36,53
2017-04-18 2017-04-17 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 590.868 -3,27 16,06 -321.244 9.490.640
2017-04-18 2017-04-17 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 10.000 610.868 1,66 1,20 12.000 733.042
2017-03-16 2017-03-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -10.000 27.375 -26,76
2017-03-16 2017-03-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -10.000 600.868 -1,64 15,02 -150.188 9.024.316
2017-03-16 2017-03-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -10.000 610.868 -1,61 15,03 -150.265 9.179.208
2017-03-16 2017-03-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 10.000 620.868 1,64 1,20 12.000 745.042
2017-02-17 2017-02-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -20.000 37.375 -34,86
2017-02-17 2017-02-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 610.868 -3,17 13,01 -260.170 7.946.476
2017-02-17 2017-02-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 20.000 630.868 3,27 1,20 24.000 757.042
2017-01-20 2017-01-18 4 XENT Intersect ENT, Inc.
Stock Options (Right to buy)
A - Award 252.000 252.000
2017-01-20 2017-01-18 4 XENT Intersect ENT, Inc.
Common Stock
A - Award 54.000 610.868 9,70
2016-10-19 2016-10-17 4 XENT Intersect ENT, Inc.
Stock Options (Right to buy)
M - Exercise -400 56.975 -0,70
2016-10-19 2016-10-17 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -400 556.868 -0,07 18,00 -7.200 10.023.624
2016-10-19 2016-10-17 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 400 557.268 0,07 1,20 480 668.722
2016-05-20 2016-05-18 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
A - Award 3.240 3.240
2016-04-19 2016-04-18 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -4.000 57.375 -6,52
2016-04-19 2016-04-18 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -8.500 556.868 -1,50 19,50 -165.740 10.858.258
2016-04-19 2016-04-18 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 4.000 565.368 0,71 1,20 4.800 678.442
2016-04-19 2016-04-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -20.000 61.375 -24,58
2016-04-19 2016-04-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 561.368 -3,44 18,34 -366.848 10.296.836
2016-04-19 2016-04-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 20.000 581.368 3,56 1,20 24.000 697.642
2016-03-16 2016-03-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -9.000 561.368 -1,58 18,01 -162.084 10.109.845
2016-01-20 2016-01-15 4 XENT Intersect ENT, Inc.
Stock Options (Right to buy)
A - Award 225.000 225.000
2016-01-20 2016-01-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -8.000 81.375 -8,95
2016-01-20 2016-01-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -12.500 570.368 -2,14 19,26 -240.808 10.987.911
2016-01-20 2016-01-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 8.000 582.868 1,39 1,20 9.600 699.442
2015-12-16 2015-12-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -6.820 574.868 -1,17 19,85 -135.408 11.413.717
2015-11-17 2015-11-16 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -6.818 581.688 -1,16 18,00 -122.732 10.471.082
2015-10-16 2015-10-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -6.818 588.506 -1,15 18,72 -127.619 11.015.655
2015-09-16 2015-09-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -6.818 595.324 -1,13 25,99 -177.229 15.475.031
2015-08-19 2015-08-17 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -6.818 602.142 -1,12 28,51 -194.385 17.167.369
2015-07-16 2015-07-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -19.318 608.960 -3,07 29,62 -572.153 18.035.934
2015-07-01 2015-06-29 4 NVRO NEVRO CORP
Stock Option (right to buy)
A - Award 5.853 5.853
2015-06-16 2015-06-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -19.318 628.278 -2,98 29,30 -565.992 18.407.729
2015-05-19 2015-05-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -19.318 647.596 -2,90 23,69 -457.628 15.341.031
2015-04-17 2015-04-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -19.318 666.914 -2,82 25,96 -501.544 17.314.755
2015-03-18 2015-03-16 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -19.318 686.232 -2,74 23,56 -455.057 16.164.950
2015-02-19 2015-02-17 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -19.318 705.550 -2,67 22,69 -438.343 16.009.564
2015-01-23 2015-01-21 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
A - Award 150.000 150.000
2014-07-23 3 XENT Intersect ENT, Inc.
Common Stock
1.475.918
2014-07-23 3 XENT Intersect ENT, Inc.
Common Stock
777.232
2014-07-23 3 XENT Intersect ENT, Inc.
Common Stock
1.475.918
2014-07-23 3 XENT Intersect ENT, Inc.
Common Stock
777.232
2012-06-26 2012-06-22 4 KNSY KENSEY NASH CORP
Common Stock
D - Sale to Issuer -5.100 0 -100,00 38,50 -196.350
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)